Anti-Microbial Resistance & Infectious Disease Biotechnology

This session examines advanced solutions addressing the global antimicrobial crisis. Topics include novel antibiotics, phage therapy, antimicrobial peptides, host-directed therapies, and microbiome modulation. Policy discussions will address stewardship programs, incentives for antibiotic innovation, and global initiatives to combat resistance. Attendees will gain a comprehensive understanding of emerging biotech strategies for infectious disease control.

    Related Conference of Anti-Microbial Resistance & Infectious Disease Biotechnology

    January 29-30, 2026

    19th World Drug Delivery Summit

    Paris, France
    February 10-11, 2026

    40th World Congress on Pharmacology and Therapeutics

    Barcelona, Spain
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, UK
    March 23-24, 2026

    36th Annual European Pharma Congress

    London, UK
    March 24-25, 2026

    11th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France

    Anti-Microbial Resistance & Infectious Disease Biotechnology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in